Journals / Göztepe Tıp Dergisi / 2010 / Cilt: 25 - Sayı: 3

Is human plasental lactogen a good marker with free estradiol for determining the fetal well being

Human plasental laktojen, serbest östradiol ile birlikte fetal iyiliğin belirlenmesinde bir belirteç olabilir mi?

Pages
104–110
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: For determining the fetal prognose USG, NST, CST and serum free estriol levels are correlated with each other and none of them is superior to another and HPL is not a prognostic marker to determine the fetal well being.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study is the impact of human plasental lactogen and to determine the fetal well being with free estriol in 40 weeks gestation pregnancies.
📊
Key Findings & Data:Material and Methods: A total of 40 pregnant women with a gestational age of 40 weeks applied to Göztepe Training Hospital Obstetrics and Gynecology clinic were enrolled in this study. 40 pregnant women were divided into two equal groups as high risk and no risk.
💡
Conclusion & Impact:Conclusion: For determining the fetal prognose USG, NST, CST and serum free estriol levels are correlated with each other and none of them is superior to another and HPL is not a prognostic marker to determine the fetal well being.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study is the impact of human plasental lactogen and to determine the fetal well being with free estriol in 40 weeks gestation pregnancies. Material and Methods: A total of 40 pregnant women with a gestational age of 40 weeks applied to Göztepe Training Hospital Obstetrics and Gynecology clinic were enrolled in this study. 40 pregnant women were divided into two equal groups as high risk and no risk. All pregnant women were followed from the first day to the end of labor and obstetric ultrasonography, NST, CST were performed. Serum free estriol and HPL levels, the duration they are followed up, amniotic fluid indexes, the way of parturation, if the fetus painted with meconium or not and the apgar scores were all noted. Results: The decline at the levels of free estriol is a good prognostic factor to determine the fetal well being and is correlated with the other prognostic markers as NST, CST and USG. From another view determining levels of free estriol is not as practical as the other prognostic markers because sequential and biochemical analyses are required. When serum HPL levels were compared, there is no statistical differance with high risk or no risk groups. At pregnant women without any maternal patology, there is not any expressive role of HPL for determining the fetal well being. Conclusion: For determining the fetal prognose USG, NST, CST and serum free estriol levels are correlated with each other and none of them is superior to another and HPL is not a prognostic marker to determine the fetal well being.

Özet

gebelerin takibinde human plasental laktojenin önemi ve serbest östriol ile birlikte fetusun iyilik halini belirlemek için değerlendirilmeleridir. Gereç ve Yöntem: Göztepe Eğitim Hastanesi Kadın Hastalıkları ve Doğum Kliniği, Gebe polikliniğine kontrol ve takip amaçlı başvuran 40 miadındaki gebe çalışmaya alındı. 40 gebe riskli ve risksiz olarak 20 şerli iki gruba ayrıldı. Bütün gebeler takibe alındıkları ilk günden doğumlarına kadar USG, NST, CST, Free östriol ve HPL plazma değerleri ile takip süreleri amniotik indeksleri HPL, free östriol ve NST sonuçları, doğum şekli, mekonyumlu olup olmadıkları, apgar skorları kaydedildi Bulgular: Free östriol değerlerindeki düşme fetal prognozu belirlemede anlamlı bulunmuş olup bu diğer prognoz belirleyicileri NST, CST, USG ile koreledir. Bu açıdan değerlendirildiğinde ardışık alınması gereken ve biokimyasal işlemleri gerektirmesi nedeni ile free östriolun diğer prognoz belirleyicileri kadar pratik olmadığı düşünülmüştür. HPL değerleri riskli ve risksiz gruplar arasında karşılaştırıldığında istatiksel fark bulunmamıştır. Maternal patolojisi olmayan gebelerde fetal prognozu belirlemede HPL’nin anlamlı rolü yoktur. Sonuç: Gebelikte fetal prognozu değerlendirmekte USG, NST, CST ve free östriol değerleri korele ve aralarında anlamlı bir fark bulunmadı. Buna göre HPL’nin fetal prognozu belirlemede etkin bir parametre olarak kullanılamayacağı vurgulandı.

🔖

Cite This Article

TOPRAK, T., EVREN, İ., SÜER, N., ÇAKAR, E. (2022). Is human plasental lactogen a good marker with free estradiol for determining the fetal well being. Göztepe Tıp Dergisi, Cilt: 25 - Sayı: 3, 104–110. https://ajindex.com/articles/526180

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Buster JE, Sakakini J, Killam AP, et al. Serum unconjugated estriol levels in the third trimester and their relationship to gestational age. Am J Obstet Gynecol 1976; 125:672
  2. Sperof L, Glass R, Kase NG. Beşinci Basım, 1996
  3. Distler W, Gabbe SG, Freman RK, Mestman JH, Goebelsmann U. Estriol in pregnency: V. Unconjugated and total plasma estriol in the management of pregnant diabetic patient, Am J Obstet Gynecol 1978; 130:424
  4. Tulchinsky D, Frigoletto FD, Ryan KJ, et al. Plasma estetrol as an index of fetal well being. J Clin Endocrinol Metab 1965; 40:560
  5. Yen and Jaffe. Third Edition 943, 1991
  6. Petraglia F, Sutton S, Vale W. Neurotransmitters and peptides modulate the release of immunoreactive corticotropinreleasing factor from human cultured plecental cells. Am J Obstet Gyneco 1989; 160:247
  7. Korda AR, Challis JJ, Anderson ABM. Assesment of plasental Function in normal and pathological pregnancies by estimationof plasma estradiol levels after injection of dehydroepiandrosterone sulfate. Br J Obstet Gynecol 1975; 82:656
  8. Klopper A, Jandial V. The conversion of dehydroandrosterone to estrogen: a dynamic placental function test. Eur J Obstet Gynecol Reprod Biol 1975; 5:93
  9. Kundu N, Carmody PJ, Didolkar SM. Sequential determination of serum human placental lactojen, estriol, and estetrol for assesment of fetal morbidity; Obsteetrics and Gynecology 1978; 52:5
  10. Walknowska ER, Holmgren PA, Schoultz B. Placental alkaline phosphatase compared with human placentallaktojen and oestriol in High Risk Pregnancies. Gynecol Obstet Invest 1985; 18:206-211
  11. Gunter HH, Berger L, Messner U, Niesert S. Estriol and human placental lactogen as risk indicators in pregnancies of diabetic and hypertensive patients. Z Geburtshilfe Neonatal 1995; 199(4):142-7.